The US Cosmetic Ingredient Review has long prioritized conducting safety assessments based on ingredient frequency of use (FOU), but historically that data has been limited to voluntary information submitted by industry to the US Food and Drug Administration, which can paint an incomplete and potentially inaccurate picture of the cosmetic products market.
New Era For CIR: Expert Panel Meets As Mandatorily Reported Ingredient Data Pours In From FDA
Now that reporting of cosmetic ingredient use to FDA is no longer voluntary, the Cosmetic Ingredient Review is wading through a tide of data generated by MoCRA registration and listing deadlines.
More from Ingredients & Safety
More from Beauty
• By
Counterfeit beauty products cost the US industry an estimated $3bn in 2023, says a trade expert during the Personal Care Products Council’s Beauty Collective Summit.
• By
Cosmetic companies should conduct audits to identify products that will be required to disclose fragrance allergens and begin the work of adjusting labels, particularly for smaller packaging, says a director at Registrar Corp., during a 12 March webinar on MoCRA and labeling.
• By
Cosmetics companies brace for the impact of Trump administration tariffs as industry experts seeing an opportunity for an exemption urge stakeholders to reach out to lawmakers. The issue was discussed during PCPC’s recent Beauty Collective Summit.